Form EFFECT ABVC BIOPHARMA, INC.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 1, 2024 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Appoints Intellectual Property Veteran Dean Becker as Chief Licensing Officer
- Royalty Management Holding Corporation Reports 38% Revenue Growth and Profitable Second Quarter
- TechMediaBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF)(Frankfurt: Y0N) (WKN: A422EZ) Completes Acquisition of Quantum.IQ Technologies
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
